<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский онкологический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-9984</issn><issn publication-format="electronic">2412-9119</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39987</article-id><article-id pub-id-type="doi">10.17816/onco39987</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">CLINICAL CASE OF SUCCESSFUL LONG-TERM TREATMENT OF THE PATIENT WITH METASTATIC CERVICAL CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>Возможность длительного лекарственного лечения с использованием бевацизумаба у больной диссеминированным раком шейки матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bagrova</surname><given-names>S. G</given-names></name><name xml:lang="ru"><surname>Багрова</surname><given-names>Светлана Геннадьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, науч. сотр. отд-ния химиотерапии</p></bio><email>s.bagrova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gorbunova</surname><given-names>V. A</given-names></name><name xml:lang="ru"><surname>Горбунова</surname><given-names>В. А.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ФГБУ Российский онкологический научный центр им. Н. Н. Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2013</year></pub-date><volume>18</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2013)</issue-title><issue-title xml:lang="ru">№1 (2013)</issue-title><fpage>47</fpage><lpage>48</lpage><history><date date-type="received" iso-8601-date="2020-07-22"><day>22</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Эко-Вектор"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjonco.com/1028-9984/article/view/39987">https://rjonco.com/1028-9984/article/view/39987</self-uri><abstract xml:lang="en"><p>Modern approach to individualization of the patients’ treatment, based on careful supervision over the minimum manifestations of an illness and competent combination of chemotherapy, target agents, radiotherapy allow to supervise a disease for a long time.</p></abstract><trans-abstract xml:lang="ru"><p>Современный подход к индивидуализации лечения больных, основанный на тщательном наблюдении за минимальными проявлениями болезни, и грамотное сочетание цитостатиков, таргетных препаратов и лучевой терапии позволяют контролировать заболевание в течение длительного времени.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>chemotherapy</kwd><kwd>individualization of treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>химиотерапия</kwd><kwd>индивидуализация лечения</kwd></kwd-group></article-meta></front><body></body><back><ref-list/></back></article>
